Inclusive of all taxes
MONTRELIEF LC TAB by Dr Precision is a cutting-edge dual-action antiallergic tablet formulated to provide comprehensive relief from allergic rhinitis, hay fever, skin allergies, and associated symptoms such as sneezing, nasal congestion, runny nose, and itching. Combining Montelukast, a leukotriene receptor antagonist, with Levocetirizine, a third-generation non-sedating antihistamine, MONTRELIEF LC TAB offers fast-acting and long-lasting symptom control. This unique synergy effectively targets both leukotriene and histamine pathways, addressing airway inflammation, bronchoconstriction, and histamine-induced reactions. Manufactured under stringent WHO-GMP and ISO-certified conditions by Bluepill Express and marketed by Dr Precision, this tablet ensures premium quality, purity, and potency. The once-daily, non-drowsy formula improves patient compliance by providing 24-hour relief without impairing daytime alertness, making it ideal for individuals managing chronic and seasonal allergies. Packaged in moisture-resistant, high-barrier blister packs, MONTRELIEF LC TAB maintains stable efficacy throughout shipping and storage. It is well-suited for pharmaceutical exporters, wholesalers, and healthcare providers targeting a global market with a reliable, clinically validated allergy treatment option.
Key Features
| Features | Description |
|---|---|
| Composition | Combination of Montelukast (10 mg) and Levocetirizine (5 mg) per tablet |
| Dual Mechanism | Montelukast blocks leukotrienes; Levocetirizine acts as a non-sedating antihistamine |
| Indications | Effective in allergic rhinitis, chronic urticaria, hay fever, nasal congestion, and skin allergies |
| Onset of Action | Fast-acting with sustained 24-hour symptom relief |
| Dosage Form | Oral film-coated tablet |
| Patient Compliance | Once-daily dosing with low incidence of drowsiness |
| Manufacturing Standards | Produced in WHO-GMP and ISO-certified facilities |
| Packaging | Moisture-resistant, high-barrier blister packs for enhanced shelf stability |
| Market Suitability | Ideal for pharmaceutical exporters, wholesalers, and third-party marketers |
| Safety Profile | Clinically tested for efficacy, purity, potency, and safety |
| Attributes | Description |
|---|---|
| Montelukast Dosage | 10 mg per tablet |
| Levocetirizine Dosage | 5 mg per tablet |
| Pharmacological Action | Montelukast - leukotriene receptor antagonist; Levocetirizine - third-generation antihistamine |
| Tablet Type | Film-coated, oral |
| Shelf Life | Typically 2 years from manufacturing date |
| Packaging | Blister pack with moisture and oxygen barrier |
| Storage Conditions | Store below 30°C, protected from moisture and light |
| Regulatory Compliance | Manufactured under GMP, WHO-GMP, and ISO-certified facilities |
| Indicated Use | Management of allergic rhinitis, urticaria, hay fever, and related allergies |
| Dosage Frequency | Once daily |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
MONTRELIEF LC TAB contains Levocetirizine, a third-generation antihistamine which selectively targets H1 receptors without crossing the blood-brain barrier significantly, minimizing sedation and enabling daytime use without drowsiness.
Yes, the dual-action formulation combining Montelukast and Levocetirizine effectively manages multi-symptom allergies involving respiratory issues like rhinitis and skin conditions such as chronic urticaria.
This product is manufactured in WHO-GMP and ISO-certified facilities, ensuring compliance with international quality standards for potency, purity, and safety, making it suitable for export and global distribution.
MONTRELIEF LC TAB is supplied in moisture-resistant, high-barrier blister packs that protect the tablets from humidity, oxygen, and light, ensuring stability and efficacy during storage and shipment across diverse climates.
The tablet is designed for once-daily administration, which supports sustained 24-hour control of allergic symptoms and improves patient adherence.
Country Of Origin: India
MONTRELIEF LC TAB is a dual-action antiallergic tablet containing Montelukast and Levocetirizine. It is formulated to relieve allergic rhinitis, hay fever, sneezing, runny nose, nasal congestion, and skin allergies by combining anti-leukotriene and antihistamine effects for fast and long-lasting relief.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
MONTRELIEF LC TAB is an advanced combination medicine that offers powerful relief from allergic conditions, including allergic rhinitis, chronic urticaria, and seasonal hay fever. It contains Montelukast, a leukotriene receptor antagonist, and Levocetirizine, a third-generation non-sedating antihistamine. The synergy of these two agents allows MONTRELIEF LC TAB to target a broader range of allergic symptoms, including nasal congestion, runny nose, sneezing, itchy eyes, and skin rashes.
Montelukast works by blocking leukotrienes, which are inflammatory mediators responsible for airway inflammation, bronchoconstriction, and mucus secretion. Levocetirizine complements this action by inhibiting histamine release at the H1 receptor level, reducing itching, swelling, and other histamine-induced symptoms. Unlike older antihistamines, Levocetirizine does not typically cause drowsiness, making the formulation suitable for daytime use without impairing alertness or productivity.
MONTRELIEF LC TAB is especially useful for patients who require long-term management of respiratory allergies or for those exposed to high pollen or dust levels. It is also beneficial for individuals suffering from dual allergic symptoms such as rhinitis and urticaria. The combination is often preferred by healthcare professionals because of its rapid onset, high tolerability, and sustained 24-hour symptom control.
Manufactured by Bluepill Express, this formulation adheres to the highest quality standards under WHO-GMP and ISO-certified facilities. The product is thoroughly tested for purity, potency, and shelf stability, ensuring each batch meets international pharmaceutical standards. Its once-daily dosage increases patient compliance while reducing the need for multiple medications or repeated dosing.
MONTRELIEF LC TAB is widely accepted across global markets due to its clinically proven efficacy and safety profile. It is ideal for pharmaceutical exporters, wholesalers, and third-party marketers looking to expand their range of allergy medications under a trusted brand. The product is available in moisture-resistant, high-barrier blister packs to preserve its integrity in varying climates and shipping conditions.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
